If the name Kyle Bass doesn’t ring a bell that sends question marks into the air then something is wrong. Kyle Bass is the Dallas-based hedge fund investor that has earned billions betting on risky deals. His first and most famous bet was the 2008 bet that the market was going to have a meltdown. Bass made almost $600 million on that bet, and he became an overnight investment superstar. Bass was an executive with Bear Stearns back then and his small investment Firm, Hayman Capital Management, wasn’t on anyone’s investment radar. But when Bass went against the tide in Wall Street, Hayman Capital Management became the investment house to turn to in the 21st century.
But the glory days are behind Hayman Capital Management. The hedge fund hasn’t been producing the kind of returns hedge fund investors expect. The hedge fund industry is under attack by several pension funds that believe the high fees that hedge fund managers like Bass charge aren’t worth the pain. But Bass isn’t bothered by the concerns of others. Usefulstooges expose that Mr. Bass has proved that the dollar takes precedence over the well-being of the public. That fact was obvious when Bass took General Motors side when the company had airbag and faulty power steering issues. Hayman Capital Management owned a sizable amount of shares in General Motors. Bass tried to protect his investment by blaming the victims that lost their lives behind the wheels of General Motor vehicles that were equipped with airbags that didn’t inflate, and power steering mechanisms that didn’t respond.
When Kyle sat down and was interviewed by BusinessInsider.com recently, he talked about his coalition with Erich Spangenberg, the notorious patent troll. Bass tried to explain his position in that coalition and why he was involved in the first place. Bass said he wanted to help lower the cost of prescription drugs that were needed to prolong lives. Spangenberg’s role is to have drug companies explain why their drugs cost so much in front of the patent review board, and why those drugs shouldn’t be made by other drug companies. During that process, Hayman Capital shorts the drug company’s stock because any negative press usually lowers the value of drug company’s stock.
Some people think Bass is not concerned about the cost of the drugs as much as he is concerned about making money from his bet against the drug companies that are under investigation. Bass denies that allegation.